CN103865873A - 亚全能干细胞分泌的外来体及其应用 - Google Patents
亚全能干细胞分泌的外来体及其应用 Download PDFInfo
- Publication number
- CN103865873A CN103865873A CN201210535397.5A CN201210535397A CN103865873A CN 103865873 A CN103865873 A CN 103865873A CN 201210535397 A CN201210535397 A CN 201210535397A CN 103865873 A CN103865873 A CN 103865873A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- exosome
- sub
- myeloid
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 122
- 210000001808 exosome Anatomy 0.000 title claims abstract description 60
- 210000004027 cell Anatomy 0.000 claims abstract description 80
- 230000006698 induction Effects 0.000 claims abstract description 25
- 230000004069 differentiation Effects 0.000 claims abstract description 24
- 108700011259 MicroRNAs Proteins 0.000 claims abstract description 15
- 239000002679 microRNA Substances 0.000 claims abstract description 15
- 210000001519 tissue Anatomy 0.000 claims abstract description 15
- 108091072960 Homo sapiens miR-3142 stem-loop Proteins 0.000 claims abstract description 7
- 108091072687 Homo sapiens miR-3191 stem-loop Proteins 0.000 claims abstract description 7
- 108091055441 Homo sapiens miR-4456 stem-loop Proteins 0.000 claims abstract description 7
- 108091023102 Homo sapiens miR-4711 stem-loop Proteins 0.000 claims abstract description 7
- 108091023106 Homo sapiens miR-4714 stem-loop Proteins 0.000 claims abstract description 7
- 238000000338 in vitro Methods 0.000 claims abstract description 4
- 230000001939 inductive effect Effects 0.000 claims description 28
- 108010023082 activin A Proteins 0.000 claims description 26
- 230000028327 secretion Effects 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 21
- 239000006228 supernatant Substances 0.000 claims description 21
- 101150057663 Foxa2 gene Proteins 0.000 claims description 20
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 20
- 101150088608 Kdr gene Proteins 0.000 claims description 20
- 101100310648 Mus musculus Sox17 gene Proteins 0.000 claims description 20
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 19
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 17
- 210000004024 hepatic stellate cell Anatomy 0.000 claims description 17
- 230000006907 apoptotic process Effects 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 15
- 238000001514 detection method Methods 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 12
- 101100540419 Danio rerio kdrl gene Proteins 0.000 claims description 10
- 101100445364 Mus musculus Eomes gene Proteins 0.000 claims description 10
- 101100310657 Mus musculus Sox1 gene Proteins 0.000 claims description 10
- 102000007354 PAX6 Transcription Factor Human genes 0.000 claims description 10
- 101150081664 PAX6 gene Proteins 0.000 claims description 10
- 229930006000 Sucrose Natural products 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
- 101150059272 TBX6 gene Proteins 0.000 claims description 10
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 claims description 10
- 101100445365 Xenopus laevis eomes gene Proteins 0.000 claims description 10
- 239000007850 fluorescent dye Substances 0.000 claims description 10
- 230000005012 migration Effects 0.000 claims description 10
- 238000013508 migration Methods 0.000 claims description 10
- 239000005720 sucrose Substances 0.000 claims description 10
- 238000001262 western blot Methods 0.000 claims description 10
- 210000003734 kidney Anatomy 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 7
- 239000012228 culture supernatant Substances 0.000 claims description 7
- 230000001464 adherent effect Effects 0.000 claims description 6
- 238000004113 cell culture Methods 0.000 claims description 6
- 229930195712 glutamate Natural products 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 230000003248 secreting effect Effects 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 210000003556 vascular endothelial cell Anatomy 0.000 claims description 6
- 101150084967 EPCAM gene Proteins 0.000 claims description 5
- 101150075625 Gsc gene Proteins 0.000 claims description 5
- 238000001085 differential centrifugation Methods 0.000 claims description 5
- 210000003981 ectoderm Anatomy 0.000 claims description 5
- 210000004039 endoderm cell Anatomy 0.000 claims description 5
- 238000005374 membrane filtration Methods 0.000 claims description 5
- 210000003716 mesoderm Anatomy 0.000 claims description 5
- 238000000108 ultra-filtration Methods 0.000 claims description 5
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 4
- 210000000577 adipose tissue Anatomy 0.000 claims description 4
- 210000002569 neuron Anatomy 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 230000001766 physiological effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 14
- 241000282414 Homo sapiens Species 0.000 description 11
- 230000006378 damage Effects 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 208000014674 injury Diseases 0.000 description 9
- 239000002609 medium Substances 0.000 description 8
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 239000006285 cell suspension Substances 0.000 description 6
- 230000029087 digestion Effects 0.000 description 5
- 229940049906 glutamate Drugs 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 210000001161 mammalian embryo Anatomy 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 101150096672 CEL1 gene Proteins 0.000 description 4
- 210000000447 Th1 cell Anatomy 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000024908 graft versus host disease Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 206010016654 Fibrosis Diseases 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 210000005087 mononuclear cell Anatomy 0.000 description 3
- 230000000324 neuroprotective effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical class OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- -1 CD31 Proteins 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 description 2
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 2
- 210000004241 Th2 cell Anatomy 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000003399 chemotactic effect Effects 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 238000002316 cosmetic surgery Methods 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000004072 osteoblast differentiation Effects 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 238000011476 stem cell transplantation Methods 0.000 description 2
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 1
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- 102100025222 CD63 antigen Human genes 0.000 description 1
- 102100027221 CD81 antigen Human genes 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- 206010013183 Dislocation of vertebra Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102100037241 Endoglin Human genes 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 102000006354 HLA-DR Antigens Human genes 0.000 description 1
- 108010058597 HLA-DR Antigens Proteins 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 101000934368 Homo sapiens CD63 antigen Proteins 0.000 description 1
- 101000914479 Homo sapiens CD81 antigen Proteins 0.000 description 1
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 102100025304 Integrin beta-1 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 238000011579 SCID mouse model Methods 0.000 description 1
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 description 1
- 102000002070 Transferrins Human genes 0.000 description 1
- 108010015865 Transferrins Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 241000405217 Viola <butterfly> Species 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 238000011095 buffer preparation Methods 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 229940011399 escin Drugs 0.000 description 1
- 229930186222 escin Natural products 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000000848 glutamatergic effect Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000035778 pathophysiological process Effects 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- AVPCPPOOQICIRJ-UHFFFAOYSA-L sodium glycerol 2-phosphate Chemical compound [Na+].[Na+].OCC(CO)OP([O-])([O-])=O AVPCPPOOQICIRJ-UHFFFAOYSA-L 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000007801 sublethal irradiation Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 210000002444 unipotent stem cell Anatomy 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 108010047303 von Willebrand Factor Proteins 0.000 description 1
- 102100036537 von Willebrand factor Human genes 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210535397.5A CN103865873B (zh) | 2012-12-12 | 2012-12-12 | 亚全能干细胞分泌的外来体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210535397.5A CN103865873B (zh) | 2012-12-12 | 2012-12-12 | 亚全能干细胞分泌的外来体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103865873A true CN103865873A (zh) | 2014-06-18 |
CN103865873B CN103865873B (zh) | 2017-04-05 |
Family
ID=50904884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210535397.5A Active CN103865873B (zh) | 2012-12-12 | 2012-12-12 | 亚全能干细胞分泌的外来体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103865873B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105349487A (zh) * | 2015-11-16 | 2016-02-24 | 中国人民解放军第二军医大学 | 一种基于外泌体的促人骨髓间充质干细胞增殖的方法 |
CN107629999A (zh) * | 2017-10-18 | 2018-01-26 | 清华大学深圳研究生院 | 一种增加间充质干细胞外泌体产生及分泌的方法 |
CN107937342A (zh) * | 2017-11-06 | 2018-04-20 | 中国人民解放军第四军医大学 | 一种通过内皮细胞来源的外泌体扩增神经干细胞的方法 |
CN110384714A (zh) * | 2019-07-05 | 2019-10-29 | 中国医学科学院基础医学研究所 | 亚全能干细胞的外泌体及其在促进血管新生和伤口愈合中的用途 |
CN110804607A (zh) * | 2019-11-18 | 2020-02-18 | 深圳市润科生物科技有限公司 | 一种高浓度人源间充质干细胞裂解液的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101748096A (zh) * | 2008-12-17 | 2010-06-23 | 北京汉氏联合生物技术有限公司 | 亚全能干细胞、其制备方法及其用途 |
CN102014934A (zh) * | 2008-02-22 | 2011-04-13 | 新加坡科技研究局 | 间充质干细胞颗粒 |
WO2012075912A1 (zh) * | 2010-12-09 | 2012-06-14 | 中国医学科学院基础医学研究所 | 亚全能干细胞产品及其表观遗传修饰标签 |
WO2012125471A1 (en) * | 2011-03-11 | 2012-09-20 | Children's Medical Center Corporation | Methods and compositions relating to mesenchymal stem cell exosomes |
-
2012
- 2012-12-12 CN CN201210535397.5A patent/CN103865873B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102014934A (zh) * | 2008-02-22 | 2011-04-13 | 新加坡科技研究局 | 间充质干细胞颗粒 |
CN101748096A (zh) * | 2008-12-17 | 2010-06-23 | 北京汉氏联合生物技术有限公司 | 亚全能干细胞、其制备方法及其用途 |
WO2012075912A1 (zh) * | 2010-12-09 | 2012-06-14 | 中国医学科学院基础医学研究所 | 亚全能干细胞产品及其表观遗传修饰标签 |
WO2012125471A1 (en) * | 2011-03-11 | 2012-09-20 | Children's Medical Center Corporation | Methods and compositions relating to mesenchymal stem cell exosomes |
Non-Patent Citations (7)
Title |
---|
COLLINO F等: "Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs.", 《PLOS ONE》 * |
FANG等: "Systemic infusion of FLK1+mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice.", 《TRANSPLANTATION》 * |
SOKOLOVAA V等: "Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy.", 《COLLOIDS SURF B BIOINTERFACES》 * |
史明霞等: "胎儿骨髓源Flk1+CD31-CD34-干细胞归巢机制的初步研究", 《第11次中国实验血液学会议论文汇编》 * |
孙昭等: "全能干细胞研究进展", 《中国生物工程学会第四次会员代表大会暨学术讨论会论文摘要集》 * |
赵春华: "RosA26小鼠骨髓来源Flk-1+CD34-成体亚全能干细胞的生物学特性与分化潜能研究", 《第10届全国实验血液学会议论文摘要汇编》 * |
赵春华等: "亚全能干细胞群生物学特性及移植应用研究", 《中国微循环》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105349487A (zh) * | 2015-11-16 | 2016-02-24 | 中国人民解放军第二军医大学 | 一种基于外泌体的促人骨髓间充质干细胞增殖的方法 |
CN105349487B (zh) * | 2015-11-16 | 2020-07-17 | 中国人民解放军第二军医大学 | 一种基于外泌体的促人骨髓间充质干细胞增殖的方法 |
CN107629999A (zh) * | 2017-10-18 | 2018-01-26 | 清华大学深圳研究生院 | 一种增加间充质干细胞外泌体产生及分泌的方法 |
CN107937342A (zh) * | 2017-11-06 | 2018-04-20 | 中国人民解放军第四军医大学 | 一种通过内皮细胞来源的外泌体扩增神经干细胞的方法 |
CN107937342B (zh) * | 2017-11-06 | 2021-07-06 | 中国人民解放军第四军医大学 | 一种通过内皮细胞来源的外泌体扩增神经干细胞的方法 |
CN110384714A (zh) * | 2019-07-05 | 2019-10-29 | 中国医学科学院基础医学研究所 | 亚全能干细胞的外泌体及其在促进血管新生和伤口愈合中的用途 |
CN110804607A (zh) * | 2019-11-18 | 2020-02-18 | 深圳市润科生物科技有限公司 | 一种高浓度人源间充质干细胞裂解液的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103865873B (zh) | 2017-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pittenger | Mesenchymal stem cells from adult bone marrow | |
Wang et al. | Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell | |
Oskowitz et al. | Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic | |
CN101748096B (zh) | 亚全能干细胞、其制备方法及其用途 | |
Chieregato et al. | Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue | |
ES2803499T3 (es) | Composiciones y métodos de células grasas marrones | |
Darzi et al. | Osteogenic differentiation of stem cells derived from menstrual blood versus bone marrow in the presence of human platelet releasate | |
Seruya et al. | Clonal population of adult stem cells: life span and differentiation potential | |
Bai et al. | Isolation and characterization of mesenchymal stem cells from chicken bone marrow | |
Domev et al. | Efficient engineering of vascularized ectopic bone from human embryonic stem cell–derived mesenchymal stem cells | |
BR112014020119A2 (pt) | cultura de células-tronco mesenquimais | |
Mohanty et al. | Immunophenotypic characterization and tenogenic differentiation of mesenchymal stromal cells isolated from equine umbilical cord blood | |
CN101155912A (zh) | 显示出内皮细胞特征的脂肪来源的成年基质细胞 | |
KR100802011B1 (ko) | 층분리배양법을 이용한 골수에서의 중간엽 줄기세포분리방법 | |
JPWO2005063967A1 (ja) | 哺乳動物の骨髄細胞または臍帯血由来細胞と脂肪組織を利用した心筋細胞の誘導 | |
Park et al. | The correlation between human adipose-derived stem cells differentiation and cell adhesion mechanism | |
CN103865873A (zh) | 亚全能干细胞分泌的外来体及其应用 | |
Dai et al. | Skin epithelial cells in mice from umbilical cord blood mesenchymal stem cells | |
WO2020146874A1 (en) | Fibroblast regenerative cells | |
CN110885786A (zh) | 细胞因子在促进牙髓干细胞分泌外泌体中的应用 | |
Wang et al. | Human amniotic epithelial cells regulate osteoblast differentiation through the secretion of TGFβ1 and microRNA-34a-5p | |
Zuttion et al. | In vitro heterogeneity of porcine adipose tissue-derived stem cells | |
Jun-Jiang et al. | Vascular endothelial growth factor 165-transfected adipose-derived mesenchymal stem cells promote vascularization-assisted fat transplantation | |
Esposito et al. | Culture conditions allow selection of different mesenchymal progenitors from adult mouse bone marrow | |
CN104745529B (zh) | 瘦素在诱导胚胎干细胞分化为造血干/祖细胞中的用途及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190202 Address after: 262700 Middle Section of Xiangyang Road, Yangkou Town, Shouguang City, Weifang City, Shandong Province Patentee after: Shouguang Jinwo Real Estate Co., Ltd. Address before: 100005 Dongdan No. 3, No. 5, Dongcheng District, Beijing Patentee before: Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200325 Address after: 266200 Room 601, building B, No. 168, Ningdong Road, Blue New Area, Jimo Provincial Economic Development Zone, Qingdao, Shandong Province Patentee after: QINGDAO GUOAOYUAN BIOENGINEERING TECHNOLOGY GROUP Co.,Ltd. Address before: 262700 Middle Section of Xiangyang Road, Yangkou Town, Shouguang City, Weifang City, Shandong Province Patentee before: Shouguang Jinwo Real Estate Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200421 Address after: 266200 No.168, Ningdong Road, Blue New District, Jimo Economic Development Zone, Qingdao, Shandong Province Patentee after: Qingdao Guoaoyuan Huasheng Biotechnology Group Co., Ltd. Address before: 266200 Room 601, building B, No. 168, Ningdong Road, Blue New Area, Jimo Provincial Economic Development Zone, Qingdao, Shandong Province Patentee before: QINGDAO GUOAOYUAN BIOENGINEERING TECHNOLOGY GROUP Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 266200 No.168 Ningdong Road, Blue New District, Jimo Economic Development Zone, Qingdao City, Shandong Province Patentee after: Micro energy Life Technology Group Co.,Ltd. Address before: 266200 No.168 Ningdong Road, Blue New District, Jimo Economic Development Zone, Qingdao City, Shandong Province Patentee before: Qingdao Guoaoyuan Huasheng Biotechnology Group Co.,Ltd. |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Chunhua Inventor after: Wang Shihua Inventor before: Zhao Chunhua |